Diagnostics

  • Interview: How AI could predict your health from one drop of blood

    iCarbonX is applying deep learning to gain greater insights into personal health and is advancing AI-driven drug development. Health Tech World speaks to founder and CEO Dr Wang Jun to find out more. The last decade has seen major advancements in artificial intelligence, genomics, and data analytics, and iCarbonX is harnessing these technologies to advance [...]

  • Interview: World-first handheld device can predict preterm birth risk

    Preterm birth affects one in 10 babies globally, but a first-of-its-kind handheld diagnostic device hopes to transform these outcomes by predicting the risk ahead of time. Health Tech World speaks to Dr Shaolin Liang of Every Baby to find out more. Every hour, 125 babies die from preterm birth complications. This figure reveals a desperate [...]

  • Off-the-shelf cancer vaccine could lower risk of relapse, study suggests

    An off-the-shelf cancer vaccine has shown potential in lowering the risk of pancreatic and colorectal cancer returning after surgery. The jab works by training the immune system to target and destroy cancer cells that may return after treatment, aiming to reduce relapse. Unlike personalised mRNA vaccines tailored to individual tumours, this non-personalised vaccine is already [...]

  • Transforming hearing health with OTC tech

    LXE Hearing is a hearing health company developing clinically-validated mobile tech for hearing care and diagnosis. We speak to CEO and Health Tech World Awards ‘Leader of the Year’ Nic Klopper about the transformative impact of the OTC hearing tech and what it takes to lead in the health tech space. Nic Klopper and three [...]

  • Research roundup: Saliva testing for diabetes risk and more

    Health Tech World explored the latest research developments in the world of health technology. Saliva testing may reveal early signs of diabetes and obesity Measuring elevated levels of insulin - called hyperinsulinemia - in blood, is a proven way to measure metabolic health and can show risk of developing future health concerns, including Type 2 [...]

  • Harnessing ‘an enormous amount of statistical power’ to transform brain health diagnosis

    Creyos is an online cognitive assessment platform built on more than three decades of research and a vast - and growing - trove of data. The platform enables healthcare providers to evaluate working memory, attention, reasoning and executive function, potentially speeding up diagnoses and reducing waiting lists. Health Tech World catches up with co-founder Professor [...]

  • Digital pathology: Forging our own future

    By Liam Canavan, Healthcare Lead at Loadbalancer.org  Liam partners with medical imaging providers and hospitals worldwide, building strategic alliances and using cutting-edge technology to tackle tough data storage problems and ultimately enhance patient care. The ARPA-H INDEX programme and DPA have outlined a broad digital strategy for pathology, yet simultaneously acknowledge that infrastructure shortfalls are [...]

  • New breast screening trial aims to detect cancer earlier

    A UK study is investigating whether Fast MRI scans can detect breast cancer earlier than mammograms in women with average breast density. The Fast MRI Dyamond study will scan around 1,000 women aged 50 to 52 across six NHS sites including Cheltenham, Swindon and Truro over the next three and a half years. The Fast [...]

  • Hospitals can now make cancer therapies on-site

    New UK rules allow hospitals to prepare advanced blood cancer treatments locally, reducing delays for patients. New regulations introduced on 23 July will allow hospitals across the UK to manufacture personalised cancer therapies on-site, instead of sending cells to distant labs. The Medicines and Healthcare products Regulatory Agency (MHRA) has created the legal framework, said [...]

  • Automated system tracks schizophrenia in mice

    An automated system has allowed researchers to observe schizophrenia-related behaviours in mice in a more natural environment, which could support future psychiatric studies. The IntelliCage platform uses microchipped mice and automated data tracking to monitor behaviour without human contact, helping to reduce interference in preclinical models of mental illness. Researchers from Fujita Health University in [...]